戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ntaining the cDNA for LL-37/hCAP-18, a human cathelicidin antimicrobial peptide.
2 ability of PilB to mediate GBS resistance to cathelicidin antimicrobial peptides.
3 ate immune responses, such as the release of cathelicidin antimicrobial peptides.
4 deI and ompD are important for resistance to cathelicidin antimicrobial peptide, a mouse AMP produced
5                                              Cathelicidin antimicrobial peptides are effectors of inn
6                                              Cathelicidin antimicrobial peptides are essential for th
7                                              Cathelicidin antimicrobial peptides are present at sites
8                                          The cathelicidin antimicrobial peptide (Camp) gene was upreg
9  its analogs induced expression of the human cathelicidin antimicrobial peptide (CAMP) gene.
10                                              Cathelicidin antimicrobial peptide (CAMP) is a naturally
11 r Typhi and S. Typhimurium will induce human cathelicidin antimicrobial peptide (CAMP) production, an
12  (S1P), regulates production of a major AMP, cathelicidin antimicrobial peptide (CAMP), in response t
13 of the multifunctional antimicrobial peptide cathelicidin antimicrobial peptide (CAMP).
14 lls to produce an innate immune element, the cathelicidin antimicrobial peptide (CAMP).
15 or (VDR)-dependent mechanisms regulate human cathelicidin antimicrobial peptide (CAMP)/LL-37 in vario
16  CD14 and TLR2, complementing an increase in cathelicidin antimicrobial peptide expression.
17 ction was mediated through the production of cathelicidin antimicrobial peptide from adipocytes becau
18                            These include the cathelicidin antimicrobial peptide gene and the TLR core
19 )D) enhances innate immunity by inducing the cathelicidin antimicrobial peptide (hCAP).
20    The genes encoding lysozyme, lactoferrin, cathelicidin antimicrobial peptide (hCAP18/LL-37), cathe
21 let-derived antimicrobials in serum, and the cathelicidin antimicrobial peptide LL-37.
22 ly localizes with elevated expression of the cathelicidin antimicrobial peptide LL-37.
23 h AD, but not psoriasis, is deficient in the cathelicidin antimicrobial peptide (LL-37) and human bet
24 esponding to residues 7-27 of the only human cathelicidin antimicrobial peptide, LL37, is shown to ex
25     These observations provide evidence that cathelicidin antimicrobial peptides mediate an anti-infl
26 mycin, the susceptibility of the bacteria to cathelicidin antimicrobial peptides or serum complement
27                              The presence of cathelicidin antimicrobial peptides provides an importan
28                      Mast cells (MC) express cathelicidin antimicrobial peptides that act as broad-sp
29 , organelles that also contain precursors of cathelicidins, antimicrobial peptides that undergo prote
30                            Administration of cathelicidin antimicrobial peptides to mice with late-st
31     Using MCs derived from mice deficient in cathelicidin antimicrobial peptide, we showed that antim
32 tibility to reactive oxygen species and host cathelicidin antimicrobial peptides, which correlated wi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。